These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8670252)

  • 1. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
    Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.
    Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M
    Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
    Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease.
    Soto-Otero R; Méndez-Alvarez E; Riguera-Vega R; Quiñoá-Cabana E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Brain Res; 1998 Aug; 802(1-2):155-62. PubMed ID: 9748553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
    Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
    Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
    J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat.
    Ayala A; Parrado J; Cano J; Machado A
    Brain Res; 1994 Feb; 638(1-2):334-6. PubMed ID: 8199872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies.
    Michaluk J; Krygowska-Wajs A; Karolewicz B; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(1):19-25. PubMed ID: 12020040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion.
    Naoi M; Matsuura S; Takahashi T; Nagatsu T
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1213-9. PubMed ID: 2742585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
    Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
    Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoquinoline neurotoxins in the brain and Parkinson's disease.
    Nagatsu T
    Neurosci Res; 1997 Oct; 29(2):99-111. PubMed ID: 9359458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]raclopride to dopamine D2 receptors in the mouse brain.
    Ishiwata K; Koyanagi Y; Saitoh T; Taguchi K; Toda J; Sano T; Senda M
    J Neural Transm (Vienna); 2001; 108(10):1111-25. PubMed ID: 11725814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tryptophan hydroxylase by 6,7-dihydroxy-N-cyanomethyl-1,2,3,4-tetrahydroisoquinoline, a cyanomethyl derivative of dopamine formed from cigarette smoke.
    Minami M; Yu PH; Davis BA; Takahashi T; Shimomura Y; Naoi M
    Neurosci Lett; 1993 Oct; 160(2):217-20. PubMed ID: 8247357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
    J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Saitoh T; Abe K; Ishikawa M; Nakatani M; Shimazu S; Satoh N; Yoneda F; Taguchi K; Horiguchi Y
    Eur J Med Chem; 2006 Feb; 41(2):241-52. PubMed ID: 16412536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-cyclohexyl- and 1-cyclohexyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats.
    Abe M; Munakata H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
    Brain Res Bull; 2016 Mar; 121():201-8. PubMed ID: 26876935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.